SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
小米粥
Lv3
220 积分
2023-11-25 加入
最近求助
最近应助
互助留言
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer
12天前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
14天前
已完结
Anal cancer and screening guidelines for human papillomavirus in men
19天前
已关闭
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC
20天前
已完结
Neoadjuvant Chemo-Immunotherapy for Early-Stage Non–Small Cell Lung Cancer
20天前
已完结
Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
29天前
已完结
What is the current role of immunotherapy in EGFR mutant advanced NSCLC?
1个月前
已完结
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06–2018 study)
1个月前
已完结
BCAA-producing Clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism
1个月前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
1个月前
已完结
没有进行任何应助
点赞,点赞,点赞,感谢,速度真快
12天前
不要了【积分已退回】
19天前
感谢,点赞,点赞,点赞
20天前
感谢,点赞,速度真快,感谢
20天前
感谢,感谢,感谢,点赞,速度真快
29天前
感谢,感谢,点赞,速度真快
1个月前
感谢,点赞,速度真快
1个月前
感谢,感谢,感谢,点赞,速度真快
2个月前
感谢,速度真快
2个月前
感谢,点赞,速度真快,速度真快
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论